CSIMarket
 


Melinta Therapeutics, Inc.  (CEMP)
Other Ticker:  
 
 

CEMP's Revenue Growth by Quarter and Year

Melinta Therapeutics,'s Revenue results by quarter and year




CEMP Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 35.49 0.00 7.95
III Quarter September 15.87 34.08 1.72 3.97
II Quarter June 15.96 12.02 0.86 3.42
I Quarter March 14.08 14.84 4.87 2.68
FY   45.91 96.43 7.45 18.02



CEMP Revenue third quarter 2019 Y/Y Growth Comment
Melinta Therapeutics, Inc. reported drop in Revenue in the third quarter 2019 by -53.43% to $ 15.87 millions, from the same quarter in 2018.
The fall in the third quarter 2019 Melinta Therapeutics, Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 204.95%.

Looking into third quarter 2019 results within Major Pharmaceutical Preparations industry 202 other companies have achieved higher Revenue growth. While Melinta Therapeutics, Inc.' s Revenue meltdown of -53.43% ranks overall at the positon no. 3839 in the third quarter 2019.




CEMP Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - 37.31 %
III Quarter September -53.43 % 1881.4 % -56.68 % 58.8 %
II Quarter June 32.78 % 1297.67 % -74.85 % -32.28 %
I Quarter March -5.12 % 204.72 % 81.72 % -80.8 %
FY   - 1194.36 % -58.66 % -33.99 %

Financial Statements
Melinta Therapeutics,'s third quarter 2019 Revenue $ 15.87 millions CEMP's Income Statement
Melinta Therapeutics,'s third quarter 2018 Revenue $ 34.08 millions Quarterly CEMP's Income Statement
New: More CEMP's historic Revenue Growth >>


CEMP Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 4.14 % - 100.25 %
III Quarter September -0.56 % 183.53 % 100 % 16.08 %
II Quarter June 13.35 % -19 % -82.34 % 27.61 %
I Quarter March -60.33 % - -38.74 % -53.71 %
FY (Year on Year)   - 1194.36 % -58.66 % -33.99 %




Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #521
Overall #3839

Revenue Y/Y Growth Statistics
High Average Low
1884.74 % 204.95 % -100 %
(Sep 30 2018)   (Dec 31 2017)
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #521
Overall #3839
Revenue Y/Y Growth Statistics
High Average Low
1884.74 % 204.95 % -100 %
(Sep 30 2018)   (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Melinta Therapeutics,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
465.3 % 34.45 % -100 %
(Mar 31 2015)  


CEMP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Melinta Therapeutics, Inc. reported decrease in Revenue sequentially by -0.56% to $ 15.87 millions, from $ 15.96 millions released in the previous reporting period.

Some seasonal factors which usually elevate III. Quarter 2019 performance, could not recover the III. Quarter for the Melinta Therapeutics, Inc., Kabir Kadam , Major Pharmaceutical Preparations industry expert situated in Nagpur pointed out, he voiced some caution conserning Melinta Therapeutics,'s direction, he detected further difficulties onward for Melinta Therapeutics, and continued that average sequential Revenue growth is at 34.45% for Melinta Therapeutics,.

Within Major Pharmaceutical Preparations industry 153 other companies have achieved higher Revenue quarter on quarter growth. While Melinta Therapeutics,'s Revenue growth quarter on quarter, overall rank is 2456.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #154
Healthcare Sector #358
Overall #2456
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #154
Healthcare Sector #358
Overall #2456
Revenue Q/Q Growth Statistics
High Average Low
465.3 % 34.45 % -100 %
(Mar 31 2015)  


CEMP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Melinta Therapeutics, Inc. disclosed decrease in Revenue from the second quarter by -0.56% to $ 15.87 millions, from $ 15.96 millions declared a quarter before.

Even cyclical circumstance were not able to salvage the III. Quarter for the Melinta Therapeutics, Inc., Kabir Kadam , Major Pharmaceutical Preparations industry expert situated in Nagpur said and mentioned that average sequential Revenue growth is at 34.45% for CEMP.

Within Major Pharmaceutical Preparations industry 153 other companies have achieved higher Revenue quarter on quarter growth. While Melinta Therapeutics,'s Revenue growth quarter on quarter, overall rank is 2456.


Melinta Therapeutics,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Revenue 12 Months Ending $ 81.40 $ 99.61 $ 95.67 $ 96.43 $ 0.00
Y / Y Revenue Growth (TTM) - 452.88 % - - -
Year on Year Revenue Growth Overall Ranking # 769 # 608 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -18.28 % 4.11 % -0.79 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 2449 # 88 # 0 # 0 # 0




Cumulative Revenue growth Comment


In the Healthcare sector 171 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 608 to 769.

Revenue TTM Q/Q Growth Statistics
High Average Low
452.88 %
67.33 %
-50.81 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 172
Overall # 769

Revenue TTM Y/Y Growth Statistics
High Average Low
255.67 %
34.79 %
-50.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 338
S&P 500 # 2449
Cumulative Revenue growth Comment


In the Healthcare sector 171 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 608 to 769.

Revenue TTM Q/Q Growth Statistics
High Average Low
452.88 %
67.33 %
-50.81 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 172
Overall # 769

Revenue TTM Y/Y Growth Statistics
High Average Low
255.67 %
34.79 %
-50.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 338
S&P 500 # 2449




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CEMP's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CEMP's Competitors
Revenue Growth for Melinta Therapeutics,'s Suppliers
Revenue Growth for CEMP's Customers

You may also want to know
CEMP's Annual Growth Rates CEMP's Profitability Ratios CEMP's Asset Turnover Ratio CEMP's Dividend Growth
CEMP's Roe CEMP's Valuation Ratios CEMP's Financial Strength Ratios CEMP's Dividend Payout Ratio
CEMP's Roa CEMP's Inventory Turnover Ratio CEMP's Growth Rates CEMP's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Vaso Corporation-0.32%$ -0.325 millions
Nature s Sunshine Products inc -0.34%$ -0.342 millions
Myomo Inc -0.39%$ -0.388 millions
Integer Holdings Corporation-0.49%$ -0.492 millions
Prestige Consumer Healthcare Inc -0.54%$ -0.538 millions
Dariohealth Corp -0.59%$ -0.585 millions
Alpha Pro Tech Ltd -0.64%$ -0.636 millions
Vivus Inc-0.65%$ -0.652 millions
Supernus Pharmaceuticals inc -0.83%$ -0.831 millions
Pediatrix Medical Group Inc -0.89%$ -0.890 millions
Atrion Corporation-1.00%$ -0.996 millions
Livanova Plc-1.28%$ -1.276 millions
Assembly Biosciences Inc -1.28%$ -1.280 millions
Magellan Health inc -1.33%$ -1.325 millions
3m Company-1.97%$ -1.975 millions
Endo International Plc-2.15%$ -2.152 millions
Intersect Ent Inc -2.47%$ -2.473 millions
Owens and Minor inc-2.67%$ -2.672 millions
United Therapeutics Corporation-2.71%$ -2.714 millions
Amgen Inc -2.83%$ -2.829 millions
Arcturus Therapeutics Holdings Inc -3.07%$ -3.067 millions
Theravance Biopharma inc -3.20%$ -3.201 millions
Enovis Corporation-3.30%$ -3.296 millions
Lantheus Holdings Inc -3.51%$ -3.514 millions
Invacare Holdings Corporation-3.59%$ -3.592 millions
Inogen Inc -3.70%$ -3.704 millions
Sonida Senior Living Inc -3.93%$ -3.926 millions
Pressure Biosciences Inc -3.95%$ -3.950 millions
Dynatronics Corporation-3.96%$ -3.963 millions
China Health Industries Holdings Inc -4.10%$ -4.104 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com